Published in Am Rev Respir Dis on June 01, 1966
In vitro activity of MK-0366 against clinical urinary pathogens including gentamicin-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother (1982) 5.54
Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis (1992) 4.20
Studies on Histoplasmosis in a Rural Community. Am J Public Health Nations Health (1947) 4.04
5-Fluorocytosine in human cryptococcosis. Antimicrob Agents Chemother (Bethesda) (1968) 3.08
Activity of minocycline against Acinetobacter calcoaceticus var. anitratus (syn. Herellea vaginicola) and Serratia marcescens. Antimicrob Agents Chemother (1975) 2.92
Efficacy of UK-109496, a new azole antifungal agent, in an experimental model of invasive aspergillosis. Antimicrob Agents Chemother (1996) 2.52
The diagnosis of invasive aspergillosis by an enzyme-linked immunosorbent assay for circulating antigen. J Infect Dis (1985) 2.44
Treatment of experimental invasive aspergillosis with novel amphotericin B/cholesterol-sulfate complexes. J Infect Dis (1989) 2.08
Antibiotic synergy in experimental infection with Pseudomonas. II. The effect of carbenicillin, cephalothin, or cephanone combined with tobramycin or gentamicin. J Infect Dis (1974) 2.00
Progressive disseminated histoplasmosis. A prospective study of 26 patients. Ann Intern Med (1972) 1.99
Cognitive dysfunction in a patient with long-term occupational exposure to ethylene oxide. Role of ethylene oxide as a causal factor. J Occup Med (1992) 1.96
Therapy of cryptococcosis with a combination of flucytosine and amphotericin B. J Infect Dis (1975) 1.88
Histoplasmosis: Animal Reservoirs and Other Sources in Nature of Pathogenic Fungus, Histoplasma. Am J Public Health Nations Health (1950) 1.84
Synergy of carbenicillin and gentamicin in experimental infection with Pseudomonas. J Infect Dis (1971) 1.77
Aspergillus species endocarditis. The new face of a not so rare disease. Am J Med (1974) 1.74
In vitro antibacterial activity of a new 1-oxa cephalosporin compound. Yale J Biol Med (1980) 1.70
Coagulase-negative staphylococcus. Ann N Y Acad Sci (1970) 1.68
Current concepts in cryptococcosis. Eur J Clin Microbiol Infect Dis (1989) 1.65
Effect of immunosuppression and amphotericin B on Aspergillus antigenemia in an experimental model. J Infect Dis (1988) 1.65
Gram-negative bacillary meningitis. Am J Med (1975) 1.64
In vitro susceptibility of Cryptococcus neoformans to amphotericin B, hamycin, and 5-fluorocytosine. Antimicrob Agents Chemother (Bethesda) (1968) 1.62
Development of meningitis during cephalothin therapy. Ann Intern Med (1973) 1.62
North American blastomycosis: a study of 40 patients. Medicine (Baltimore) (1968) 1.56
Chemotherapeutic agents for the pulmonary mycoses. Report of the Committee on Fungus Diseases and Subcommittee on Therapy, American College of Chest Physicians. Chest (1971) 1.53
The epidemiology of pseudallescheriasis complicating transplantation: nosocomial and community-acquired infection. Mycoses (1990) 1.53
Bacterial urinary tract infections in diabetes. Infect Dis Clin North Am (1997) 1.51
Preliminary studies on a hyphaforming mutant of Cryptococcus neoformans. Mycologia (1966) 1.46
Optimal therapy for enterococcal endocarditis. Am J Med (1984) 1.46
Detection, significance, and therapy of bacteriuria in pregnancy. Update in the managed health care era. Infect Dis Clin North Am (1997) 1.43
Association between serum inhibitory and bactericidal concentrations and therapeutic outcome in bacterial endocarditis. Am J Med (1982) 1.42
Antiendotoxin monoclonal antibodies for gram-negative sepsis: guidelines from the IDSA. Clin Infect Dis (1992) 1.41
Efficacy of SCH 39304 in treatment of experimental invasive aspergillosis. Antimicrob Agents Chemother (1991) 1.39
Combination therapy in experimental invasive aspergillosis. J Infect Dis (1993) 1.36
Thoracic cross-sectional imaging of amyloidosis. AJR Am J Roentgenol (1997) 1.35
Bacteriuria in pregnancy. Infect Dis Clin North Am (1987) 1.32
Meningoencephalitis due to pathogenic free-living amoebae. Report of two cases. JAMA (1968) 1.30
The role of fluconazole in the early treatment and prophylaxis of experimental invasive aspergillosis. J Infect Dis (1991) 1.29
Intraventricular administration of amphotericin B. Use of subcutaneous reservoir in four patients with mycotic meningitis. JAMA (1965) 1.28
An experimental model of amphotericin B nephrotoxicity with renal tubular acidosis. J Lab Clin Med (1971) 1.27
The effect and critical duration of increased tissue pressure on susceptibility to bacterial infection. Br J Exp Pathol (1965) 1.25
Antibiotic sensitivities of nonpigmented serratia marcescens to gentamicin and carbenicillin. J Infect Dis (1969) 1.24
Bioassay for hamycin. Antimicrob Agents Chemother (Bethesda) (1965) 1.24
Carbenicillin: clinical and laboratory studies. J Infect Dis (1970) 1.23
5-fluorocytosine in human candidiasis. Antimicrob Agents Chemother (Bethesda) (1970) 1.22
Unexplained pulmonary hypertension in chronic myeloproliferative disorders. Chest (2001) 1.20
Activity of LY146032 in vitro and in experimental enterococcal pyelonephritis. Antimicrob Agents Chemother (1987) 1.19
A paradigm for human chronic osteomyelitis. J Bone Joint Surg Am (1973) 1.18
Acceleration of the inflammatory response of the renal medulla by water diuresis. J Clin Invest (1966) 1.18
Cephalexin: clinical and laboratory studies. Yale J Biol Med (1971) 1.18
A solid-phase radioimmunoassay for the measurement of antibody to Aspergillus in invasive aspergillosis. J Infect Dis (1979) 1.16
Cryptococcal infection of the central nervous system. Med Clin North Am (1985) 1.14
Laboratory and clinical studies of a new antibiotic, cephaloridine, in the treatment of gram-positive infections. Yale J Biol Med (1966) 1.14
Accuracy of grey-scale ultrasound diagnosis of abdominal and pelvic abscesses in 220 patients. Lancet (1978) 1.13
Cryptococcosis complicating sarcoidosis. Am Rev Respir Dis (1973) 1.12
Epidemic of pulmonary blastomycosis (Namekagon fever) in Wisconsin canoeists. Chest (1984) 1.12
Bacteriuria during indwelling catheter drainage. Effect of constant bladder rinse. JAMA (1966) 1.11
Aspergillus antigen detection in the diagnosis of invasive aspergillosis. J Infect Dis (1995) 1.09
Effect of water diuresis on chronic pyelonephritis. J Lab Clin Med (1968) 1.09
Laboratory and clinical studies of a new antibiotic, cephaloglycin in the treatment of urinary tract infections. Yale J Biol Med (1968) 1.08
Clinical features of extracutaneous sporotrichosis. Medicine (Baltimore) (1967) 1.08
A new method for measuring antibody using radiolabeled protein A1 in a solid-phase radioimmunoassay. J Immunol Methods (1979) 1.07
Role of the infectious disease specialist in containing costs of antibiotics in the hospital. Rev Infect Dis (1986) 1.07
Usefulness of serial antibody determinations in diagnosis of candidiasis as measured by discontinuous counterimmunoelectrophoresis using HS antigen. J Clin Microbiol (1978) 1.07
The role of liposomal amphotericin B in the treatment of systemic fungal infections. Eur J Cancer Clin Oncol (1989) 1.07
In vitro susceptibility of selected bacteria to cefaclor. Yale J Biol Med (1978) 1.06
Flucytosine. N Engl J Med (1972) 1.04
Therapeutic bronchoscopy in broncholithiasis. Am J Respir Crit Care Med (1999) 1.04
Saperconazole therapy in a rabbit model of invasive aspergillosis. Antimicrob Agents Chemother (1992) 1.03
North American blastomycosis: two autochthonous cases from Africa. Sabouraudia (1964) 1.02
Pharmacokinetics of cephalosporins in patients with normal or reduced renal function. J Infect Dis (1978) 1.01
Risk of osteoporotic fractures in women with breast cancer: a population-based cohort study. J Chronic Dis (1987) 0.99
Meningoencephalitis due to hyphae-forming Cryptococcus neoformans. Am J Clin Pathol (1971) 0.99
Clinical and laboratory studies of a new micronized preparation of hamycin in systemic mycoses in man. Antimicrob Agents Chemother (Bethesda) (1967) 0.99
External-beam radiation therapy in the treatment of diffuse tracheobronchial amyloidosis. Mayo Clin Proc (2001) 0.99
Efficacies of two new antifungal agents, the triazole ravuconazole and the echinocandin LY-303366, in an experimental model of invasive aspergillosis. Antimicrob Agents Chemother (2000) 0.99
Renal and perirenal abscesses. Infect Dis Clin North Am (1997) 0.98
Sarcoidosis presenting as a central nervous system mass lesion. Chest (1997) 0.97
Brain abscess caused by Cladosporium trichoides. Arch Intern Med (1976) 0.97
Efficacy of fluconazole in experimental invasive aspergillosis. Rev Infect Dis (1990) 0.97
Cavitary pulmonary infarct in immunocompromised hosts. Mayo Clin Proc (1995) 0.97
Pulmonary hypertension in patients with amyloidosis. Chest (2001) 0.97
Enterococcal meningitis: combined vancomycin and rifampin therapy. Am J Med (1980) 0.96
Comparative efficacy of ciprofloxacin, azlocillin, and tobramycin alone and in combination in experimental Pseudomonas sepsis. J Infect Dis (1987) 0.95
Urinary tract antiseptics. Med Clin North Am (1982) 0.95
Hamycin treatment of experimental blastomycosis in mice. Proc Soc Exp Biol Med (1965) 0.94
Whole blood phagocytic and bactericidal activity for Staphylococcus aureus. J Lab Clin Med (1972) 0.92
Synergism of oxacillin and gentamicin against enterococci. Antimicrob Agents Chemother (1975) 0.91
Pseudomonas bacteremia: can antibiotic therapy improve survival? J Lab Clin Med (1979) 0.91
Cardiac echinococcosis: case report of unusual echocardiographic appearance. Mayo Clin Proc (1995) 0.91
Imaging experimental infective endocarditis with indium-111-labeled blood cellular components. Circulation (1979) 0.91
Cefoperazone versus ceftriaxone monotherapy of nosocomial pneumonia. Diagn Microbiol Infect Dis (1992) 0.91
Cefoperazone versus combination antibiotic therapy of hospital-acquired pneumonia. Am J Med (1988) 0.91
Positive end-expiratory pressure in refractory hypoxemia. A critical evaluation. Ann Intern Med (1973) 0.90
Effect of peritoneal dialysis on serum levels of tobramycin and clindamycin. Antimicrob Agents Chemother (1975) 0.90
Tubulointerstitial nephritis and immunologic responses to Tamm-Horsfall protein in rabbits challenged with homologous urine or Tamm-Horsfall protein. J Immunol (1982) 0.90
Antibody to Tamm-Horsfall protein in patients with urinary tract obstruction and vesicoureteral reflux. J Infect Dis (1978) 0.90
Chemotherapy for the systemic mycoses: the prelude to ketoconazole. Rev Infect Dis (1981) 0.90
New drugs for the systemic mycoses: flucytosine and clotrimazole. Bull N Y Acad Med (1975) 0.89